CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? AIM2-driven inflammasome activation in heart failure Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education? Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation Statement Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients? Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up

Editorial2018 Jul;28(5):365-366.

JOURNAL:Trends Cardiovasc Med. Article Link

Novel developments in revascularization for left main coronary artery disease

Carreras ET, Bhatt DL. Keywords: DK CRUSH; LM bifurcation lesions; evidence-based

Article Link

Please click on the "Article Link" on the right to get access to this article.


Quotation

"When PCI is used to treat LM bifurcation lesions,

DK-CRUSH is the most reasonable evidence-based approach."